Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Archives of Internal Medicine|February 29, 2012
Troponin criteria for myocardial infarction after percutaneous coronary interventionVictor Novack, Michael Pencina, David J Cohen, et al.
Circulation. Cardiovascular Quality and Outcomes|November 14, 2013
Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDRMonique L Anderson, Eric D Peterson, S Andrew Peng, et al.
The American Journal of Emergency Medicine|May 25, 2013
ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDRDeborah B Diercks, Michael C Kontos, Judd E Hollander, et al.
American Heart Journal|October 17, 2012
Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarctionSergio Leonardi, Anita Y Chen, S Michael Gharacholou, et al.
The American Journal of Cardiology|May 12, 2004
Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study)Jorge F Saucedo, Luis Garza, David C Wolford, et al.
Journal of the American College of Cardiology|September 18, 2010
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) studyDominick J Angiolillo, Jorge F Saucedo, Roger Deraad, et al.
Pageof 7